Skip to main content

Repoopulation Remedy

Transplanting synthetic stool made of beneficial microbes cures deadly diarrheal infections in two patients.

Written byBeth Marie Mole
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00

WIKIMEDIA, GRAY'S ANATOMYPhony poo containing 33 isolates of commensal microbes cured two patients suffering from recurrent intestinal infections of Clostridium difficile after doctors infused the fake fecal matter into their colons during a colonoscopy. The successful insertion of synthetic stool, published today in Microbiome, provides hope for a much-needed treatment against diarrhea-causing, often drug-resistant infections by C. difficile, for which conventional fecal transplant therapies have failed to develop.

“Fecal bacteriotherapy, or ‘stool transplant,’ . . . has shown promising results in preliminary studies, but concerns about pathogen transmission, patient acceptance, and inability to standardize the treatment regimen remain,” the authors wrote in the study. “This proof-of-principle study demonstrates that a stool substitute mixture comprising a multi-species community of bacteria is capable of curing antibiotic-resistant C. difficile colitis.”

The two patients involved in the study suffered from a hyper-virulent strain of C. difficile known as ribotype 078, which was unscathed by courses of the antibiotic metronidazole and the “last resort” antibiotic, vancomycin. But 2 to 3 days after the synthetic stool transplant, both patients rid their symptoms and remained symptom-free for at least 6 months. Moreover, DNA sequencing of the patients’ stool samples taken ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell
Scientist reviewing cellular and molecular data on a computer in a laboratory.

Building Translation-Ready Biomarkers with Connected Workflows

Danaher Logo

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays